Business Description
MAIA Biotechnology Inc
NAICS : 325412
SIC : 2834
ISIN : US5526411021
Description
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.06 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -31.8 | |||||
| 3-Year EPS without NRI Growth Rate | -33.8 | |||||
| 3-Year FCF Growth Rate | -78.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.17 | |||||
| 9-Day RSI | 57.88 | |||||
| 14-Day RSI | 59.9 | |||||
| 6-1 Month Momentum % | 23.62 | |||||
| 12-1 Month Momentum % | -9.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.53 | |||||
| Quick Ratio | 1.53 | |||||
| Cash Ratio | 1.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -16.9 | |||||
| Shareholder Yield % | -9.07 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -417.33 | |||||
| ROA % | -215.25 | |||||
| ROIC % | -1365.6 | |||||
| ROCE % | -372.43 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 110 | |||||
| Price-to-Tangible-Book | 102.67 | |||||
| EV-to-EBIT | -3.2 | |||||
| EV-to-Forward-EBIT | -2.19 | |||||
| EV-to-EBITDA | -3.2 | |||||
| EV-to-Forward-EBITDA | -2.14 | |||||
| EV-to-FCF | -4.83 | |||||
| Price-to-Net-Current-Asset-Value | 102.67 | |||||
| Earnings Yield (Greenblatt) % | -31.25 | |||||
| FCF Yield % | -20.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:MAIA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MAIA Biotechnology Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.5 | ||
| Beta | 0 | ||
| Volatility % | 107.05 | ||
| 14-Day RSI | 59.9 | ||
| 14-Day ATR ($) | 0.302606 | ||
| 20-Day SMA ($) | 2.7195 | ||
| 12-1 Month Momentum % | -9.23 | ||
| 52-Week Range ($) | 0.82 - 3.59 | ||
| Shares Outstanding (Mil) | 20.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MAIA Biotechnology Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MAIA Biotechnology Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
MAIA Biotechnology Inc Frequently Asked Questions
What is MAIA Biotechnology Inc(MAIA)'s stock price today?
The current price of MAIA is $3.08. The 52 week high of MAIA is $3.59 and 52 week low is $0.82.
When is next earnings date of MAIA Biotechnology Inc(MAIA)?
The next earnings date of MAIA Biotechnology Inc(MAIA) is 2024-05-08 Est..
Does MAIA Biotechnology Inc(MAIA) pay dividends? If so, how much?
MAIA Biotechnology Inc(MAIA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers